Overview of the VEXAS Syndrome Save

A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS syndrome.
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome was discovered in 2020 and since, increasing reports have characterized this disorder. Al-Hakin et al. has reviewed the literature and included 720 patients from 33 case reports.
From this literature cohort, key clinical features included:
- cutaneous involvement (81.8%)
- constitutional symptoms (69.4%)
- respiratory disease (61.3%)
- Joint involvement (47.3%)
- Ocular disease (44.3%)
- Venous thromboembolism (41.8%)
VEXAS was complicated by myelodysplastic syndrome in 36%. There were also many under-recognised manifestations including significant respiratory and vascular complications.
Rare features included cardiac involvement (7.6%), renal disease (7.0%), and central nervous system manifestations (7.8%).
Better understanding of this novel entity will facilitate earlier diagnosis, better monitoring, and more effective therapies.

If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.